Skip to main content
Top
Published in: Comparative Hepatology 1/2004

Open Access 01-01-2004 | Proceedings

Ultrastructural characterization of the death process of hepatocytes in neonatal mouse liver

Authors: Kazunobu Sasaki, Yuji Sonoda, Ichiro Kumano, Masumi Suda

Published in: Comparative Hepatology | Special Issue 1/2004

Login to get access

Excerpt

Hematopoiesis in mouse fetal liver starts at 10 days of gestation and begins to decline after 15 days of gestation [1]. During postnatal hematopoietic involution, hepatocyte volume rapidly increases, and four types of specialized junctions; i.e., adherens junctions, desmosomes, tight junctions and gap junctions, appear to be fully developed in liver cells [2]. Neonatal livers examined by the TUNEL method contain numerous positive cells. Fetal liver contains cells undergoing apoptosis [3], and the majority of dying cells are hematopoietic cells. However, in addition, a few TUNEL-positive hepatocytes are observed in neonatal livers. The aim of this ultrastructural study was to clarify the hepatocyte death processes in mouse neonates. …
Literature
1.
go back to reference Sasaki K, Sonoda Y: Histometrical and three-dimensional analyses of liver hematopoiesis in the mouse embryo. Arch Histol Cytol. 2000, 63: 137-146. 10.1679/aohc.63.137.CrossRefPubMed Sasaki K, Sonoda Y: Histometrical and three-dimensional analyses of liver hematopoiesis in the mouse embryo. Arch Histol Cytol. 2000, 63: 137-146. 10.1679/aohc.63.137.CrossRefPubMed
2.
go back to reference Sonoda Y, Sasaki K, Suda M, Itano C: Ultrastructural studies of hepatoblast junctions and liver hematopoiesis of the mouse embryo. Acta Anatomica Nippon. 2001, 76: 473-482. Sonoda Y, Sasaki K, Suda M, Itano C: Ultrastructural studies of hepatoblast junctions and liver hematopoiesis of the mouse embryo. Acta Anatomica Nippon. 2001, 76: 473-482.
3.
go back to reference Yu H, Bauer B, Lipke GK, Phillips RL, Zant GV: Apoptosis and hematopoiesis in murine fetal liver. Blood. 1993, 81: 373-384.PubMed Yu H, Bauer B, Lipke GK, Phillips RL, Zant GV: Apoptosis and hematopoiesis in murine fetal liver. Blood. 1993, 81: 373-384.PubMed
4.
go back to reference Clarke PGH: Developmental cell death: morphological diversity and multiple mechanism. Anat Embryol. 1990, 181: 195-213. 10.1007/BF00174615.CrossRefPubMed Clarke PGH: Developmental cell death: morphological diversity and multiple mechanism. Anat Embryol. 1990, 181: 195-213. 10.1007/BF00174615.CrossRefPubMed
5.
go back to reference Zakeri Z, Bursch W, Tenniswood M, Lockshin RA: Cell death: programmed, apoptosis, necrosis, or other?. Cell Death and Differentiation. 1995, 2: 87-96.PubMed Zakeri Z, Bursch W, Tenniswood M, Lockshin RA: Cell death: programmed, apoptosis, necrosis, or other?. Cell Death and Differentiation. 1995, 2: 87-96.PubMed
6.
go back to reference Wylli AH, Kerr JFR, Currier AR: Cell death: The significance of apoptosis. Int Rev Cytol. 1980, 68: 251-306.CrossRef Wylli AH, Kerr JFR, Currier AR: Cell death: The significance of apoptosis. Int Rev Cytol. 1980, 68: 251-306.CrossRef
7.
go back to reference H–cki J, Egger L, Monney L, Conus S, Ross– T, Fellay I, Borner C: Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2. Oncogene. 2000, 19: 2286-2290. 10.1038/sj.onc.1203592.CrossRef H–cki J, Egger L, Monney L, Conus S, Ross– T, Fellay I, Borner C: Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2. Oncogene. 2000, 19: 2286-2290. 10.1038/sj.onc.1203592.CrossRef
Metadata
Title
Ultrastructural characterization of the death process of hepatocytes in neonatal mouse liver
Authors
Kazunobu Sasaki
Yuji Sonoda
Ichiro Kumano
Masumi Suda
Publication date
01-01-2004
Publisher
BioMed Central
Published in
Comparative Hepatology / Issue Special Issue 1/2004
Electronic ISSN: 1476-5926
DOI
https://doi.org/10.1186/1476-5926-2-S1-S39

Other articles of this Special Issue 1/2004

Comparative Hepatology 1/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine